Samantha O’Hara

Company: Umoja Biopharma

Job title: Allogeneic Research Lead

Seminars:

Driving Ex Vivo Expansion of Allogeneic CAR Cells Through Rapamycin-Activated Cytokine Signalling 2:15 pm

The Rapamycin Activated Cytokine Receptor (RACR) platform can be leveraged for cell therapy both in vivo and ex vivo In vivo the RACR provides controlled proliferation via rapamycin-mediated IL-2/IL-15 cytokine signalling and protection of RACR-expressing cells from the host immune system by rapamycin tolerisation Ex vivo the RACR can be leveraged to expand cells independent…Read more

day: Day 2 - Track C - Afternoon